Aceclofenac

Paracetamol / Acetaminophen (Tablets 500mg, 650mg, 1000mg; Oral Suspension 120mg, 125mg, 250mg per 5ml; Drops 100mg/ml) is a first-line non-opioid analgesic and antipyretic on the WHO Model List of Essential Medicines. It selectively inhibits central prostaglandin synthesis through peroxidase-dependent inhibition of COX enzymes in the brain and spinal cord, activates descending serotonergic inhibitory pathways, and resets the hypothalamic thermoregulatory center to reduce fever through cutaneous vasodilation and sweating. Unlike NSAIDs, it does NOT inhibit peripheral cyclooxygenase, causing zero gastric mucosal ulceration, platelet dysfunction, or renal vasoconstriction. Indicated as first-line therapy for mild-to-moderate pain (headache, toothache, dysmenorrhea, osteoarthritis) and fever of diverse etiologies.

Aceclofenac Tablets (100mg, 200mg Sustained Release) is an oral phenylacetic acid-derivative non-steroidal anti-inflammatory drug (NSAID) on the WHO Model List framework. It exhibits preferential inhibition of the COX-2 isoenzyme over COX-1, dramatically reducing synthesis of pro-inflammatory cytokines (IL-1beta, TNF-alpha) and PGE2, while stimulating synthesis of extracellular cartilage matrix components (glycosaminoglycans) in articular cartilage. Indicated for symptomatic relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute musculoskeletal pain.

Paracetamol / Acetaminophen (Tablets 500mg, 650mg, 1000mg; Oral Suspension 120mg, 125mg, 250mg per 5ml; Drops 100mg/ml) is a first-line non-opioid analgesic and antipyretic on the WHO Model List of Essential Medicines. It selectively inhibits central prostaglandin synthesis through peroxidase-dependent inhibition of COX enzymes in the brain and spinal cord, activates descending serotonergic inhibitory pathways, and resets the hypothalamic thermoregulatory center to reduce fever through cutaneous vasodilation and sweating. Unlike NSAIDs, it does NOT inhibit peripheral cyclooxygenase, causing zero gastric mucosal ulceration, platelet dysfunction, or renal vasoconstriction. Indicated as first-line therapy for mild-to-moderate pain (headache, toothache, dysmenorrhea, osteoarthritis) and fever of diverse etiologies.

Aceclofenac Tablets (100mg, 200mg Sustained Release) is an oral phenylacetic acid-derivative non-steroidal anti-inflammatory drug (NSAID) on the WHO Model List framework. It exhibits preferential inhibition of the COX-2 isoenzyme over COX-1, dramatically reducing synthesis of pro-inflammatory cytokines (IL-1beta, TNF-alpha) and PGE2, while stimulating synthesis of extracellular cartilage matrix components (glycosaminoglycans) in articular cartilage. Indicated for symptomatic relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute musculoskeletal pain.

Aceclofenac (100mg) and Thiocolchicoside (4mg/8mg, with or without Paracetamol 325mg) Tablets is a potent muscle relaxant and anti-inflammatory combination. Aceclofenac inhibits COX-2-mediated prostaglandin synthesis, reducing joint and tissue inflammation. Thiocolchicoside is a semi-synthetic sulfur derivative of colchicoside that acts as a competitive antagonist at GABA-A and glycine receptors, exerting central muscle relaxant action to eliminate painful muscle contractures without causing heavy sedative drowsiness. Indicated for acute painful musculoskeletal conditions, acute lumbago, cervical radiculopathy, sprains, spasms, and post-traumatic muscle contractures.

Paracetamol (325mg/500mg) and Chlorzoxazone (250mg) Tablets is a centrally acting skeletal muscle relaxant and analgesic combination. Chlorzoxazone inhibits multi-synaptic reflex arcs in the spinal cord and subcortical areas of the brain, relieving painful skeletal muscle spasms. Paracetamol acts centrally to alleviate associated pain and discomfort. Indicated for acute, painful musculoskeletal conditions, muscle spasms, lumbago, torticollis, and strain/sprain trauma.

Drotaverine Hydrochloride (80mg) and Aceclofenac (100mg) Tablets combines a selective phosphodiesterase-4 (PDE4) inhibitor smooth muscle relaxant with a COX-2 preferential NSAID. Drotaverine elevates cyclic AMP in visceral smooth muscle to abolish spastic contractions, while aceclofenac inhibits prostaglandin synthesis, eliminating inflammation and pain. Indicated for severe spasmodic dysmenorrhea, biliary colic, renal/ureteric colic, and spasmodic abdominal pain.

Aceclofenac (200mg sustained-release) and Rabeprazole Sodium (20mg enteric-coated) Capsules is a gastro-protective NSAID combination. Aceclofenac is a phenylacetic acid NSAID that selectively inhibits COX-2 over COX-1, relieving joint pain and inflammation in osteoarthritis and ankylosing spondylitis. Rabeprazole is a fast-acting proton pump inhibitor that suppresses gastric acid secretion by blocking parietal cell H+/K+-ATPase, neutralizing the risk of NSAID-induced gastric ulceration, erosions, and GI bleeding. Indicated for chronic arthritis pain, osteoarthritis, and ankylosing spondylitis in patients with high gastrointestinal risk.

Paracetamol / Acetaminophen (Tablets 500mg, 650mg, 1000mg; Oral Suspension 120mg, 125mg, 250mg per 5ml; Drops 100mg/ml) is a first-line non-opioid analgesic and antipyretic on the WHO Model List of Essential Medicines. It selectively inhibits central prostaglandin synthesis through peroxidase-dependent inhibition of COX enzymes in the brain and spinal cord, activates descending serotonergic inhibitory pathways, and resets the hypothalamic thermoregulatory center to reduce fever through cutaneous vasodilation and sweating. Unlike NSAIDs, it does NOT inhibit peripheral cyclooxygenase, causing zero gastric mucosal ulceration, platelet dysfunction, or renal vasoconstriction. Indicated as first-line therapy for mild-to-moderate pain (headache, toothache, dysmenorrhea, osteoarthritis) and fever of diverse etiologies.

Paracetamol / Acetaminophen (Tablets 500mg, 650mg, 1000mg; Oral Suspension 120mg, 125mg, 250mg per 5ml; Drops 100mg/ml) is a first-line non-opioid analgesic and antipyretic on the WHO Model List of Essential Medicines. It selectively inhibits central prostaglandin synthesis through peroxidase-dependent inhibition of COX enzymes in the brain and spinal cord, activates descending serotonergic inhibitory pathways, and resets the hypothalamic thermoregulatory center to reduce fever through cutaneous vasodilation and sweating. Unlike NSAIDs, it does NOT inhibit peripheral cyclooxygenase, causing zero gastric mucosal ulceration, platelet dysfunction, or renal vasoconstriction. Indicated as first-line therapy for mild-to-moderate pain (headache, toothache, dysmenorrhea, osteoarthritis) and fever of diverse etiologies.

Paracetamol / Acetaminophen (Tablets 500mg, 650mg, 1000mg; Oral Suspension 120mg, 125mg, 250mg per 5ml; Drops 100mg/ml) is a first-line non-opioid analgesic and antipyretic on the WHO Model List of Essential Medicines. It selectively inhibits central prostaglandin synthesis through peroxidase-dependent inhibition of COX enzymes in the brain and spinal cord, activates descending serotonergic inhibitory pathways, and resets the hypothalamic thermoregulatory center to reduce fever through cutaneous vasodilation and sweating. Unlike NSAIDs, it does NOT inhibit peripheral cyclooxygenase, causing zero gastric mucosal ulceration, platelet dysfunction, or renal vasoconstriction. Indicated as first-line therapy for mild-to-moderate pain (headache, toothache, dysmenorrhea, osteoarthritis) and fever of diverse etiologies.

Aceclofenac (200mg sustained-release) and Cyclobenzaprine (15mg sustained-release) Tablets combines a long-acting NSAID with a tricyclic-derivative centrally acting muscle relaxant. Cyclobenzaprine acts primarily at the brainstem to reduce tonic somatic motor activity influencing both alpha and gamma motor systems. Indicated for acute, painful musculoskeletal conditions associated with muscle spasm and stiffness (e.g., severe acute low back pain).

Aceclofenac (100mg, with or without Paracetamol 325mg) and Tizanidine (2mg) Tablets combines an NSAID with a centrally acting alpha-2 adrenergic receptor agonist muscle relaxant. Tizanidine stimulates presynaptic alpha-2 receptors in the spinal cord, inhibiting excitatory amino acid (glutamate/aspartate) release from interneurons to reduce spasticity and muscle tone. Indicated for painful muscle spasms associated with static and functional spine disorders (cervical and lumbar syndromes) and acute musculoskeletal trauma.

Aceclofenac (1.0% w/w) and Menthol (5.0% w/w) Spray is a topical non-steroidal anti-inflammatory and counterirritant formulation. Aceclofenac penetrates transcutaneously into inflamed subcutaneous tissues and synovial fluid, inhibiting local prostaglandin synthesis. Menthol stimulates cold-sensitive TRPM8 receptors to produce a cooling soothing effect followed by mild analgesic vasodilation. Indicated for localized relief of pain, sprains, strains, contusions, and musculoskeletal injuries.

Aceclofenac Gel 1.5% w/w is an evidence-based dermatological formulation. It acts by delivering targeted active therapeutic ingredients to cutaneous lesions to relieve skin pathology, restore barrier integrity, and manage dermatoses.